Camden Capital »

Omega Therapeutics shares owned by Camden Capital

Quarter-by-quarter ownership of Omega Therapeutics (OMGAQ) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Omega Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Omega Therapeutics held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Omega Therapeutics by Camden Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $15k 20k 0.75
2024-09-30 $18k 15k 1.22
2024-06-30 $21k 10k 2.07

More positions owned by Camden Capital

NVIDIA Corporation Put Option (NVDA)
Onemain Holdings (OMF)
Citigroup Com New (C)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ge Aerospace Com New (GE)
Apple (AAPL)
Micron Technology (MU)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Microsoft Corporation (MSFT)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Flagstar Financial Com New (FLG)
PNC Financial Services (PNC)

View all positions for Camden Capital

Top funds holding Omega Therapeutics

Huntington National Bank

View all funds holding Omega Therapeutics